33 results
PRE 14A
VRNA
Verona Pharma Plc
8 Mar 24
Preliminary proxy
4:18pm
packages that are designed to promote the long-term success of the Company. The policy, as proposed, is substantively the same as the prior … for the directors to know. In general, communications relating to corporate governance and long-term corporate strategy are more likely
8-K
EX-10.1
7o8fkxmudfildaij
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
EX-10.1
s5nh54y azvuri3cr
1 May 23
Departure of Directors or Certain Officers
5:21pm
8-K
EX-99.1
b3sdae26v
20 Dec 22
Regulation FD Disclosure
6:02am
8-K
EX-10.1
7vtca5uma54tlt2p93k3
17 Oct 22
Entry into a Material Definitive Agreement
6:00am
8-K
EX-1.1
2rn79cp8es 074rzw
11 Aug 22
Other Events
5:46pm
424B5
k3s0kr2sy7kxni yv
11 Aug 22
Prospectus supplement for primary offering
5:09pm
8-K
EX-99.2
91s2p r1be44j47rejna
9 Aug 22
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:17am
424B5
thzivv5k7 dv
9 Aug 22
Prospectus supplement for primary offering
12:00am
S-3
EX-1.2
0iabf2pu
19 Mar 21
Shelf registration
5:23pm
DEF 14A
n2ow7
19 Mar 21
Definitive proxy
4:02pm
10-K
0nkjurle 2h732px
25 Feb 21
Annual report
8:29am
10-K
EX-10.20
ejcp8qsmpwftxss6j7wq
25 Feb 21
Annual report
8:29am